Zenabis Global Inc. (“Zenabis”)(TSXV:ZENA) announced today that it is now licensed to process and sell cannabis oil products in Canada. The license enables Zenabis to now sell cannabis oil produced at its Atholville, New Brunswick facility, one of the largest indoor cannabis growing facilities in Canada, where Zenabis was already processing oil.

Zenabis expects to market and sell cannabis oil products to its medical clients and to adult use consumers through supply and distribution agreements that Zenabis has in place with nine Canadian jurisdictions including British Columbia, Alberta, Saskatchewan, Quebec, Nova Scotia, New Brunswick, Manitoba, Prince Edward Island, and the Yukon.

Zenabis expects to have its initial cannabis oil products available for sale in both the medical and adult use markets by early Q2, 2019, and will be launching additional formats and formulations throughout the year.

“This approval provides us with the ability to serve new and existing customers with an expanded range of adult use and medical products through new and easy to use consumption methods. This product category is incredibly important for Zenabis, as it supports our overall growth and product leadership strategy,” said Andrew Grieve, Chief Executive Officer of Zenabis. “Ingestion of cannabis oil tends to offer a longer lasting effect than vaping or smoking dried cannabis, providing medical clients and adult use consumers with a broader set of options in Zenabis products. We look forward to bringing our cannabis oil products to market and continuing to innovate and expand our product offerings. In addition, with this update to our Atholville processing license, we now have the capacity to develop a variety of additional value-added cannabis oil products, and cannabis extract products consistent with the proposed amendments to the Cannabis Regulations that allow for greater product diversity.”

Cannabis Oil: A Value-Added Product Opportunity

Cannabis oil is a value-added option for both medical clients and adult use cannabis consumers. Cannabis oil products may be sold as oral drops or sprays, or in soft gel capsules, providing consumers a convenient, controlled and discrete dose. Cannabis oil tends to have longer lasting effects when compared to vaporizing or smoking dried cannabis. Zenabis cannabis oil products are manufactured from high-grade plant material using highly engineered extraction methods to ensure the highest quality of consumer products. Zenabis values quality first and, as with all Zenabis products, our cannabis oil is tested by an independent third-party lab to ensure product safety, consistency and quality.

Zenabis Atholville License Amendment and Construction Update

Zenabis is pleased to announce that it has received license amendment approval from Health Canada for three additional flower rooms at its Zenabis Atholville facility. This represents an additional 2,100kg of annual production capacity and 10,500 sq. ft. of incremental licensed operational space. With this amendment, the combined licensed annual production capacity of Zenabis Atholville, Zenabis Stellarton, and Zenabis Delta is now 10,200kg.

Construction at Zenabis Atholville remains on budget and on schedule, with ongoing conversion work expected to add an additional 25,000kg in annual production capacity that will become operational in stages over the course of Q2 2019. 

Employee Count Surpasses 600

Zenabis’ employee count continues to grow in line with its operational footprint, largely driven by several recent license approvals from Health Canada, including the standard cultivation license granted to our facility in Stellarton, NS, and today’s announcements on the approval to process and sell cannabis oil products and the expansion of our operational space in Atholville, NB. The number of Zenabis’ employees, including contractors and seasonal workers, now exceeds 600, having been fewer than 400 as of December 1st, 2018.